ahlam1399
07-11-2015, 05:04 AM
FDA approves Otsuka and Lundbeck?s schizophrenia treatment
(Reuters) - The U.S. Food and Drug Administration approved Danish drugmaker H. Lundbeck A/S and Japan's Otsuka Pharmaceutical Co Ltd's Rexulti, an anti-psychotic drug used to treat schizophrenia.
http://rc.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/rc/1/rc.img (http://rc.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/rc/1/rc.htm)
http://rc.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/rc/2/rc.img (http://rc.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/rc/2/rc.htm)
http://rc.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/rc/3/rc.img (http://rc.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/rc/3/rc.htm)
http://da.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/a2.img (http://da.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/a2.htm)
http://adchoice.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/ach.img (http://adchoice.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/ach.htm)http://pi.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/a2t.imghttp://pi2.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/48061a81/sc/19/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=sciXR_QCDqY:jTq4d-QN_84:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=sciXR_QCDqY:jTq4d-QN_84:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=sciXR_QCDqY:jTq4d-QN_84:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=sciXR_QCDqY:jTq4d-QN_84:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=sciXR_QCDqY:jTq4d-QN_84:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/sciXR_QCDqY
(Reuters) - The U.S. Food and Drug Administration approved Danish drugmaker H. Lundbeck A/S and Japan's Otsuka Pharmaceutical Co Ltd's Rexulti, an anti-psychotic drug used to treat schizophrenia.
http://rc.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/rc/1/rc.img (http://rc.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/rc/1/rc.htm)
http://rc.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/rc/2/rc.img (http://rc.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/rc/2/rc.htm)
http://rc.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/rc/3/rc.img (http://rc.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/rc/3/rc.htm)
http://da.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/a2.img (http://da.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/a2.htm)
http://adchoice.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/ach.img (http://adchoice.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/ach.htm)http://pi.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/a2t.imghttp://pi2.feedsportal.com/r/233194567796/u/49/f/654207/c/35217/s/48061a81/sc/19/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/48061a81/sc/19/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=sciXR_QCDqY:jTq4d-QN_84:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=sciXR_QCDqY:jTq4d-QN_84:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=sciXR_QCDqY:jTq4d-QN_84:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=sciXR_QCDqY:jTq4d-QN_84:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=sciXR_QCDqY:jTq4d-QN_84:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/sciXR_QCDqY